Base Editor Scanning Reveals Activating Mutations of DNMT3A.

Area of Science:

• Molecular Biology
• Epigenetics
• Genetics

Background:

• DNA methyltransferase 3A (DNMT3A) establishes DNA methylation crucial for mammalian development.
• Loss-of-function mutations in DNMT3A, such as R882H, are implicated in developmental disorders and hematological malignancies like acute myeloid leukemia.
• Understanding DNMT3A activation mechanisms is vital for fundamental research and therapeutic strategies.

Purpose of the Study:

• To systematically identify mutations that activate DNMT3A function.
• To explore potential pharmacological intervention sites within DNMT3A.

Main Methods:

• Utilized a base editor mutational scanning strategy coupled with an enhanced DNA methylation reporter system.
• Employed an optimized cellular recruitment approach and paired isogenic cell lines, including those with the R882H mutation.

Main Results:

• Identified and validated three distinct hyperactivating mutations in or interacting with the DNMT3A regulatory ADD domain.
• Demonstrated that these activating mutations retain function even in the presence of a heterozygous R882H mutation.
• Showcased the efficacy of base editor scanning for discovering functional protein regions.

Conclusions:

• The study identified novel DNMT3A activating mutations within the ADD domain, highlighting it as a key regulatory region.
• These findings nominate specific regions of DNMT3A as potential targets for pharmacological intervention.
• The base editor scanning approach proved effective for functional discovery of protein mutations.